Detalhe da pesquisa
1.
Accelerated versus standard epirubicin followed by cyclophosphamide, methotrexate, and fluorouracil or capecitabine as adjuvant therapy for breast cancer (UK TACT2; CRUK/05/19): quality of life results from a multicentre, phase 3, open-label, randomised, controlled trial.
Lancet Oncol
; 24(12): 1359-1374, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37926100
2.
A real-world study of the first use of palbociclib for the treatment of advanced breast cancer within the UK National Health Service as part of the novel Ibrance® Patient Program.
Br J Cancer
; 129(5): 852-860, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37468569
3.
Role of front-line bevacizumab in advanced ovarian cancer: the OSCAR study.
Int J Gynecol Cancer
; 30(2): 213-220, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31780570
4.
Real-world use of bevacizumab in metastatic colorectal, metastatic breast, advanced ovarian and cervical cancer: a systematic literature review.
Future Oncol
; 15(5): 543-561, 2019 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-30379088
5.
Accelerated versus standard epirubicin followed by cyclophosphamide, methotrexate, and fluorouracil or capecitabine as adjuvant therapy for breast cancer in the randomised UK TACT2 trial (CRUK/05/19): a multicentre, phase 3, open-label, randomised, controlled trial.
Lancet Oncol
; 18(7): 929-945, 2017 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-28600210
6.
Effects of zoledronic acid and docetaxel on small GTP-binding proteins in prostate cancer.
Tumour Biol
; 36(6): 4861-9, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-25631751
7.
Celecoxib plus hormone therapy versus hormone therapy alone for hormone-sensitive prostate cancer: first results from the STAMPEDE multiarm, multistage, randomised controlled trial.
Lancet Oncol
; 13(5): 549-58, 2012 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-22452894
8.
VERONICA: Randomized Phase II Study of Fulvestrant and Venetoclax in ER-Positive Metastatic Breast Cancer Post-CDK4/6 Inhibitors - Efficacy, Safety, and Biomarker Results.
Clin Cancer Res
; 28(15): 3256-3267, 2022 08 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35583555
9.
Comparison of impedance cardiography and cardiac magnetic resonance imaging for the evaluation of cardiac function in early-stage breast cancer patients.
Physiol Meas
; 42(10)2021 11 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34547725
10.
Real-life decision-making impact of Oncotype DX.
Breast Cancer Res Treat
; 154(1): 209-10, 2015 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-26472422
11.
Multicenter Validation of the CamGFR Model for Estimated Glomerular Filtration Rate.
JNCI Cancer Spectr
; 3(4): pkz068, 2019 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-31750418
12.
Associations Between Serum Bone Biomarkers in Early Breast Cancer and Development of Bone Metastasis: Results From the AZURE (BIG01/04) Trial.
J Natl Cancer Inst
; 110(8): 871-879, 2018 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29425304
13.
Gonadotropin-Releasing Hormone Agonists During Chemotherapy for Preservation of Ovarian Function and Fertility in Premenopausal Patients With Early Breast Cancer: A Systematic Review and Meta-Analysis of Individual Patient-Level Data.
J Clin Oncol
; 36(19): 1981-1990, 2018 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29718793
14.
A randomized trial of exemestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancer.
N Engl J Med
; 350(11): 1081-92, 2004 Mar 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-15014181
15.
Long-Term Follow-Up of the Intergroup Exemestane Study.
J Clin Oncol
; 35(22): 2507-2514, 2017 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28467729
16.
Optimal sequence of hormonotherapy in advanced breast cancer.
Curr Opin Oncol
; 18(6): 572-7, 2006 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-16988577
17.
Weekly docetaxel and zoledronic acid every 4 weeks in hormone-refractory prostate cancer patients.
Cancer Chemother Pharmacol
; 57(1): 46-51, 2006 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-16001175
18.
Bevacizumab for Ovarian Cancer at High Risk of Progression: Reproducibility of Trial Results in 'Real-world' Patients.
Anticancer Res
; 36(9): 4947-50, 2016 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-27630353
19.
Pooled analysis of prospective European studies assessing the impact of using the 21-gene Recurrence Score assay on clinical decision making in women with oestrogen receptor-positive, human epidermal growth factor receptor 2-negative early-stage breast cancer.
Eur J Cancer
; 66: 104-13, 2016 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-27544930
20.
Carboplatin and weekly paclitaxel in non-small cell lung cancer patients unfit for or pretreated with chemotherapy.
Anticancer Res
; 25(3c): 2555-9, 2005.
Artigo
em Inglês
| MEDLINE | ID: mdl-16080492